Collectively, we have identified a novel mTORC1-biased mechanism that promotes elevated translation elongation, through modulation of eEF2K/eEF2 signalling, to drive progression of a mouse CLL-like disease. This evidence concerns the gene EEF2 and B-cell chronic lymphocytic leukemia.